Immunoassay Market - 2026-2032

April 2025 | 37 pages | ID: IF5C4E6FEE58EN
DataM Intelligence

Abstracts

Immunoassay Marketis is growing with a CAGR of 7.10% during the forecast period 2026-2035.

The Immunoassay Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A Immunoassay Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

By Type

• ELISA*
• Radioimmunoassay (RIA)
• Fluorescence Immunoassays (FIA)
• Chemiluminescence Immunoassays (CLIA)
• Rapid Assays
• Others

By Product Type

• Reagents & kits*
• ELISA Reagents & Kits
• Rapid Test Reagents & Kits
• ELISPOT Reagents & Kits
• Western Blot Reagents & Kits
• Others
• Analyzers
• Open-ended Systems
• Closed-ended Systems
• Software & Services

By Specimen

• Blood*

By Application

• Therapeutic Drug Monitoring*
• Drug Discovery
• Disease Diagnosis
• Infectious Disease
• Cancer
• Endocrinology
• Autoimmune Disorders
• Cardiology
• Hematology
• Others
• Other

By End-User

• Hospitals*
• Blood Banks
• Clinical Laboratories
• Pharmaceutical and Biotech Companies
• Academic Research Centers
• Others

Regional Analysis for Immunoassay Market:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

This Report Covers:

• Go-to-market Strategy.
• Neutral perspective on the market performance.
• Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
• Customized regional/country reports as per request and country level analysis.
• Potential & niche segments and regions exhibiting promising growth covered.
• Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Research Process:

Both primary and secondary data sources have been used in the global Immunoassay Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Contents

1. MARKET INTRODUCTION AND SCOPE

1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope

2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS

3. MARKET HIGHLIGHTS AND STRATEGIC TAKEAWAYS

3.1. Key Trends and Future Projections

4. SNIPPET BY TYPE

4.1. Snippet by Product Type
4.2. Snippet by Specimen
4.3. Snippet by Application
4.4. Snippet by End-User
4.5. Snippet by Region

5. DYNAMICS

5.1. Impacting Factors
  5.1.1. Drivers
    5.1.1.1. Increasing Innovation and Launches of Advanced Immunoassay Instruments
    5.1.1.2. Rising Prevalence of Chronic & Infectious Diseases
    5.1.1.3. XX
  5.1.2. Restraints
    5.1.2.1. The High Cost of Instruments & Reagents
    5.1.2.2. Complex Assay Procedures
    5.1.2.3. XX
  5.1.3. Opportunity
    5.1.3.1. Increasing Research and Development
    5.1.3.2. XX
  5.1.4. Impact Analysis

6. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK

6.1. Market Leaders and Pioneers
  6.1.1. Emerging Pioneers and Prominent Players
  6.1.2. Established leaders with the largest-selling Brand
  6.1.3. Market leaders with established Product
6.2. CXO Perspectives
6.3. Latest Developments and Breakthroughs
6.4. Case Studies/Ongoing Research
6.5. Regulatory and Reimbursement Landscape
  6.5.1. North America
  6.5.2. Europe
  6.5.3. Asia Pacific
  6.5.4. South America
  6.5.5. Middle East & Africa
6.6. Porter’s Five Force Analysis
6.7. Supply Chain Analysis
6.8. Patent Analysis
6.9. SWOT Analysis
6.10. Unmet Needs and Gaps
6.11. Recommended Strategies for Market Entry and Expansion
6.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
6.13. Pricing Analysis and Price Dynamics
6.14. Key Opinion Leaders

7. IMMUNOASSAY MARKET, BY TYPE

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  7.1.2. Market Attractiveness Index, By Type
7.2. ELISA*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Radioimmunoassay (RIA)
7.4. Fluorescence Immunoassays (FIA)
7.5. Chemiluminescence Immunoassays (CLIA)
7.6. Rapid Assays
7.7. Others

8. IMMUNOASSAY MARKET, BY PRODUCT TYPE

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  8.1.2. Market Attractiveness Index, By Product Type
8.2. Reagents & kits*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  8.2.3. ELISA Reagents & Kits
  8.2.4. Rapid Test Reagents & Kits
  8.2.5. ELISPOT Reagents & Kits
  8.2.6. Western Blot Reagents & Kits
  8.2.7. Others
8.3. Analyzers
  8.3.1. Open-ended Systems
  8.3.2. Closed-ended Systems
8.4. Software & Services

9. IMMUNOASSAY MARKET, BY SPECIMEN

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen
  9.1.2. Market Attractiveness Index, By Specimen
9.2. Blood*
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)

10. SALIVA

10.1. Urine
10.2. Other

11. IMMUNOASSAY MARKET, BY APPLICATION

11.1. Introduction
  11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  11.1.2. Market Attractiveness Index, By Application
11.2. Therapeutic Drug Monitoring*
  11.2.1. Introduction
  11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Drug Discovery
11.4. Disease Diagnosis
  11.4.1. Infectious Disease
  11.4.2. Cancer
  11.4.3. Endocrinology
  11.4.4. Autoimmune Disorders
  11.4.5. Cardiology
  11.4.6. Hematology
  11.4.7. Others
11.5. Other

12. IMMUNOASSAY MARKET, BY END-USER

12.1. Introduction
  12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  12.1.2. Market Attractiveness Index, By End-User
12.2. Hospitals*
  12.2.1. Introduction
  12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
12.3. Blood Banks
12.4. Clinical Laboratories
12.5. Pharmaceutical and Biotech Companies
12.6. Academic Research Centers
12.7. Others

13. IMMUNOASSAY MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES

13.1. Introduction
  13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    13.1.1.1. Market Attractiveness Index, By Region
13.2. North America
  13.2.1. Introduction
  13.2.2. Key Region-Specific Dynamics
  13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen
  13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  13.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    13.2.8.1. U.S
    13.2.8.2. Canada
    13.2.8.3. Mexico
13.3. Europe
  13.3.1. Introduction
  13.3.2. Key Region-Specific Dynamics
  13.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  13.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  13.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen
  13.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  13.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  13.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    13.3.8.1. Germany
    13.3.8.2. U.K.
    13.3.8.3. France
    13.3.8.4. Spain
    13.3.8.5. Italy
    13.3.8.6. Rest of Europe
13.4. South America
  13.4.1. Introduction
  13.4.2. Key Region-Specific Dynamics
  13.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  13.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  13.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen
  13.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  13.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  13.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    13.4.8.1. Brazil
    13.4.8.2. Argentina
    13.4.8.3. Rest of South America
13.5. Asia-Pacific
  13.5.1. Introduction
  13.5.2. Key Region-Specific Dynamics
  13.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  13.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  13.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen
  13.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  13.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  13.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    13.5.8.1. China
    13.5.8.2. India
    13.5.8.3. Japan
    13.5.8.4. South Korea
    13.5.8.5. Rest of Asia-Pacific
13.6. Middle East and Africa
  13.6.1. Introduction
  13.6.2. Key Region-Specific Dynamics
  13.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  13.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  13.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen
  13.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  13.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

14. COMPETITIVE LANDSCAPE AND MARKET POSITIONING

14.1. Competitive Overview and Key Market Players
  14.1.1. Market Share Analysis and Positioning Matrix
  14.1.2. Strategic Partnerships, Mergers & Acquisitions
  14.1.3. Key Developments in Product Portfolios and Innovations
  14.1.4. Company Benchmarking

15. COMPANY PROFILES

15.1. Beckman Coulter, Inc.*
  15.1.1. Company Overview
  15.1.2. Product Portfolio
    15.1.2.1. Product Description
    15.1.2.2. Product Key Performance Indicators (KPIs)
    15.1.2.3. Historic and Forecasted Product Sales
    15.1.2.4. Product Sales Volume

16. FINANCIAL OVERVIEW

16.1. Company Revenue
  16.1.1. Geographical Revenue Shares
    16.1.1.1. Revenue Forecasts
  16.1.2. Key Developments
    16.1.2.1. Mergers & Acquisitions
    16.1.2.2. Key Product Development Activities
    16.1.2.3. Regulatory Approvals, etc.
  16.1.3. SWOT Analysis
16.2. F. Hoffmann-La Roche Ltd
16.3. Siemens Healthineers AG
16.4. BioM?rieux SA
16.5. Bio-Rad Laboratories, Inc
16.6. Abbott
16.7. DiaSorin S.p.A.
16.8. BD
16.9. Thermo Fisher Scientific Inc.
16.10. Merck KGaA (LIST NOT EXHAUSTIVE)

17. ASSUMPTION AND RESEARCH METHODOLOGY

17.1. Data Collection Methods
17.2. Data Triangulation
17.3. Forecasting Techniques
17.4. Data Verification and Validation

18. APPENDIX

18.1. About Us and Services
18.2. Contact Us